Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in South Korea-Reference-Cited by-同舟云学术

Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in South Korea

Published:2017-07-24 Issue:1 Volume:12 Page:
ISSN:1746-1596
Container-title:Diagnostic Pathology
language:en
Short-container-title:Diagn Pathol

Author:

Kwon Ji Eun,Cho Nam Hoon,Choi Yeong-Jin,Lim So Dug,Cho Yong Mee,Jun Sun Young,Park Sanghui,Kim Young A.,Kim Sung-Sun,Choe Mi Sun,Lee Jung-dong,Kang Dae Yong,Ro Jae Y.,Kim Hyun-Jung

Funder

Korean Society of Urology Oncology

Inje University (KR) research Foundation

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13000-017-0639-y.pdf

Reference29 articles.

1. Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49:466–77. discussion 475-7

2. Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol. 2017;71:447–61.